1. Home
  2. OCS vs IGIC Comparison

OCS vs IGIC Comparison

Compare OCS & IGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • IGIC
  • Stock Information
  • Founded
  • OCS 2003
  • IGIC 2001
  • Country
  • OCS Switzerland
  • IGIC Jordan
  • Employees
  • OCS N/A
  • IGIC N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • IGIC Property-Casualty Insurers
  • Sector
  • OCS Health Care
  • IGIC Finance
  • Exchange
  • OCS Nasdaq
  • IGIC Nasdaq
  • Market Cap
  • OCS 1.0B
  • IGIC 1.0B
  • IPO Year
  • OCS N/A
  • IGIC N/A
  • Fundamental
  • Price
  • OCS $19.28
  • IGIC $22.00
  • Analyst Decision
  • OCS Strong Buy
  • IGIC Buy
  • Analyst Count
  • OCS 3
  • IGIC 2
  • Target Price
  • OCS $35.33
  • IGIC $31.50
  • AVG Volume (30 Days)
  • OCS 30.1K
  • IGIC 133.3K
  • Earning Date
  • OCS 05-08-2025
  • IGIC 08-05-2025
  • Dividend Yield
  • OCS N/A
  • IGIC 8.27%
  • EPS Growth
  • OCS N/A
  • IGIC 1.83
  • EPS
  • OCS N/A
  • IGIC 2.73
  • Revenue
  • OCS $847,333.00
  • IGIC $537,909,000.00
  • Revenue This Year
  • OCS $18.70
  • IGIC $6.05
  • Revenue Next Year
  • OCS $1,059.78
  • IGIC $7.01
  • P/E Ratio
  • OCS N/A
  • IGIC $8.37
  • Revenue Growth
  • OCS N/A
  • IGIC 5.21
  • 52 Week Low
  • OCS $10.79
  • IGIC $13.85
  • 52 Week High
  • OCS $23.08
  • IGIC $27.76
  • Technical
  • Relative Strength Index (RSI)
  • OCS 51.81
  • IGIC 38.17
  • Support Level
  • OCS $18.64
  • IGIC $22.57
  • Resistance Level
  • OCS $19.73
  • IGIC $23.70
  • Average True Range (ATR)
  • OCS 0.58
  • IGIC 0.62
  • MACD
  • OCS -0.07
  • IGIC -0.02
  • Stochastic Oscillator
  • OCS 36.57
  • IGIC 3.42

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About IGIC International General Insurance Holdings Ltd.

International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.

Share on Social Networks: